| NDC Code: |
0173-0859 |
| Proprietary Name: |
Breo Ellipta |
| Suffix: |
|
| Non-Proprietary Name: |
fluticasone furoate and vilanterol trifenatate |
| Dosage Form: |
POWDER |
| Method: |
RESPIRATORY (INHALATION) |
| Original Marketing Date: |
26-08-2013 |
| Category Name: |
NDA |
| Application Number: |
NDA204275 |
| Labeler: |
GLAXOSMITHKLINE LLC |
| Substance Name: |
FLUTICASONE FUROATE; VILANTEROL TRIFENATATE |
| Active Numerator Strength: |
100; 25 |
| Active Ingredient Unit: |
ug/1; ug/1 |
| Pharm Classes: |
Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
| DEA Schedule: |
|
